Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study (Q41869433)
Jump to navigation
Jump to search
scientific article published on 30 August 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study |
scientific article published on 30 August 2008 |
Statements
1 reference
Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study (English)
1 reference
Guangbi Yao
1 reference
Chengwei Chen
1 reference
Weilun Lu
1 reference
Hong Ren
1 reference
Deming Tan
1 reference
Yuming Wang
1 reference
Daozheng Xu
1 reference
Jessica Liu
1 reference
Dong Xu
1 reference
Cyril Llamoso
1 reference
30 August 2008
1 reference
1 reference
486-493
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference